{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:49:56Z","timestamp":1787060996364,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2503700"],"award-info":[{"award-number":["2022YFC2503700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2503700"],"award-info":[{"award-number":["2022YFC2503700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2503700"],"award-info":[{"award-number":["2022YFC2503700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2503700"],"award-info":[{"award-number":["2022YFC2503700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2503700"],"award-info":[{"award-number":["2022YFC2503700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04024-0","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T07:50:20Z","timestamp":1744357820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effect of TIGIT and PD1 expression on T cell function and prognosis in adult patients with acute myeloid leukemia at diagnosis"],"prefix":"10.1007","volume":"74","author":[{"given":"Dai-Hong","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Zhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"4024_CR1","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/ijms21082907","volume":"21","author":"I Nepstad","year":"2020","unstructured":"Nepstad I, Hatfield KJ, Gr\u00f8nnings\u00e6ter IS et al (2020) The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells. Int J Mol Sci 21:2907","journal-title":"Int J Mol Sci"},{"key":"4024_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140:1345\u20131377","journal-title":"Blood"},{"key":"4024_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.978786","volume":"10","author":"X Su","year":"2022","unstructured":"Su X, Ma G, Bai X et al (2022) The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia. Front Cell Dev Biol 10:978786","journal-title":"Front Cell Dev Biol"},{"key":"4024_CR4","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/JCI129204","volume":"130","author":"L Vago","year":"2020","unstructured":"Vago L, Gojo I (2020) 130 Immune escape and immunotherapy of acute myeloid leukemia. J Clin Invest 130:1552\u20131564","journal-title":"J Clin Invest"},{"key":"4024_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Schumacher TN (2018) T cell dysfunction in cancer. Cancer Cell 33:547\u2013562","journal-title":"Cancer Cell"},{"key":"4024_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/tan.13872","volume":"96","author":"SM Radwan","year":"2020","unstructured":"Radwan SM, Elleboudy NS, Nabih NA et al (2020) The immune checkpoints Cytotoxic T lymphocyte antigen-4 and Lymphocyte activation gene-3 expression is up-regulated in acute myeloid leukemia. HLA 96:3\u201312","journal-title":"HLA"},{"key":"4024_CR7","doi-asserted-by":"publisher","first-page":"1091782","DOI":"10.3389\/fonc.2022.1091782","volume":"12","author":"S Jin","year":"2022","unstructured":"Jin S, Zhang Y, Zhou F et al (2022) TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies. Front Oncol 12:1091782","journal-title":"Front Oncol"},{"key":"4024_CR8","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1158\/1078-0432.CCR-15-2626","volume":"22","author":"Y Kong","year":"2016","unstructured":"Kong Y, Zhu L, Schell TD et al (2016) T-cell immunoglobulin and ITIM domain (TIGIT) associates with CD8+ T-cell exhaustion and poor clinical outcome in AML patients. Clin Cancer Res 22:3057\u20133066","journal-title":"Clin Cancer Res"},{"key":"4024_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.686156","volume":"11","author":"L Xu","year":"2021","unstructured":"Xu L, Liu L, Yao D et al (2021) PD-1 and TIGIT are highly co-expressed on CD8+ T cells in AML patient bone marrow. Front Oncol 11:686156","journal-title":"Front Oncol"},{"key":"4024_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-017-0414-2","volume":"10","author":"Y-Z Qin","year":"2017","unstructured":"Qin Y-Z, Wang Y, Xu L-P et al (2017) The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia. J Hematol Oncol 10:44","journal-title":"J Hematol Oncol"},{"key":"4024_CR11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.12659\/MSM.905903","volume":"24","author":"Y-Z Qin","year":"2018","unstructured":"Qin Y-Z, Zhao T, Zhu H-H et al (2018) High EVI1 expression predicts poor outcomes in adult acute myeloid leukemia patients with intermediate cytogenetic risk receiving chemotherapy. Med Sci Monitor 24:758\u2013767","journal-title":"Med Sci Monitor"},{"key":"4024_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00277-008-0591-8","volume":"88","author":"G-R Ruan","year":"2009","unstructured":"Ruan G-R, Li J-L, Qin Y-Z et al (2009) Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia. Ann Hematol 88:159\u2013166","journal-title":"Ann Hematol"},{"key":"4024_CR13","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/ijlh.13864","volume":"44","author":"N Xu","year":"2022","unstructured":"Xu N, Lai Y, Chen W et al (2022) Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype. Int J Lab Hematol 44:892\u2013899","journal-title":"Int J Lab Hematol"},{"key":"4024_CR14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140:1229\u20131253","journal-title":"Blood"},{"key":"4024_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/bjh.16745","volume":"192","author":"W Duan","year":"2021","unstructured":"Duan W, Liu X, Jia J et al (2021) The loss or absence of minimal residual disease of <\u20090\u00b71% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis. Br J Haematol 192:265\u2013271","journal-title":"Br J Haematol"},{"key":"4024_CR16","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1182\/blood-2012-11-468348","volume":"121","author":"H-H Zhu","year":"2013","unstructured":"Zhu H-H, Zhang X-H, Qin Y-Z et al (2013) MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial. Blood 121:4056\u20134062","journal-title":"Blood"},{"key":"4024_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"X-H Zhang","year":"2021","unstructured":"Zhang X-H, Chen J, Han M-Z et al (2021) The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol 14:145","journal-title":"J Hematol Oncol"},{"key":"4024_CR18","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E et al (2021) Integrated analysis of multimodal single-cell data. Cell 184:3573-3587.e29","journal-title":"Cell"},{"key":"4024_CR19","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J et al (2019) Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16:1289\u20131296","journal-title":"Nat Methods"},{"key":"4024_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41421-022-00417-y","volume":"8","author":"G You","year":"2022","unstructured":"You G, Zhang M, Bian Z et al (2022) Decoding lymphomyeloid divergence and immune hyporesponsiveness in G-CSF-primed human bone marrow by single-cell RNA-seq. Cell Discov 8:59","journal-title":"Cell Discov"},{"key":"4024_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo X, Zhang Y, Zheng L et al (2018) Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med 24:978\u2013985","journal-title":"Nat Med"},{"key":"4024_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.immuni.2022.12.001","volume":"56","author":"A Chow","year":"2023","unstructured":"Chow A, Uddin FZ, Liu M et al (2023) The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer. Immunity 56:93-106.e6","journal-title":"Immunity"},{"key":"4024_CR23","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMcibr2119477","volume":"386","author":"DA Braun","year":"2022","unstructured":"Braun DA, Wu CJ (2022) Tumor-infiltrating T cells \u2014 a portrait. N Engl J Med 386:992\u2013994","journal-title":"N Engl J Med"},{"key":"4024_CR24","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, Qin S, Si W et al (2021) Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374:abe6474","journal-title":"Science"},{"key":"4024_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clim.2017.08.021","volume":"190","author":"M Wang","year":"2018","unstructured":"Wang M, Bu J, Zhou M et al (2018) CD8+T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients. Clin Immunol (Orlando, Fla) 190:64\u201373","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"4024_CR26","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00262-021-02886-8","volume":"70","author":"R Liang","year":"2021","unstructured":"Liang R, Zhu X, Lan T et al (2021) TIGIT promotes CD8+T cells exhaustion and predicts poor prognosis of colorectal cancer. Cancer Immunol Immunother CII 70:2781\u20132793","journal-title":"Cancer Immunol Immunother CII"},{"key":"4024_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000978","volume":"8","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhou Q, Wang Z et al (2020) Intratumoral TIGIT+ CD8+ T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer. J Immunother Cancer 8:e000978","journal-title":"J Immunother Cancer"},{"key":"4024_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaad.2019.03.012","volume":"81","author":"WJ Lee","year":"2019","unstructured":"Lee WJ, Lee YJ, Choi ME et al (2019) Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes. J Am Acad Dermatol 81:219\u2013227","journal-title":"J Am Acad Dermatol"},{"key":"4024_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.58","volume":"5","author":"Y Kong","year":"2015","unstructured":"Kong Y, Zhang J, Claxton DF et al (2015) PD-1hiTIM-3+ T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation. Blood Cancer J 5:e330","journal-title":"Blood Cancer J"},{"key":"4024_CR30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood.2022015522","volume":"140","author":"V Gournay","year":"2022","unstructured":"Gournay V, Vallet N, Peux V et al (2022) Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse. Blood 140:1305\u20131321","journal-title":"Blood"},{"key":"4024_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12716","volume":"17","author":"Y Song","year":"2018","unstructured":"Song Y, Wang B, Song R et al (2018) T-cell immunoglobulin and ITIM domain contributes to CD8+ T-cell immunosenescence. Aging Cell 17:e12716","journal-title":"Aging Cell"},{"key":"4024_CR32","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1111\/cas.15932","volume":"114","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Deng C, Zhu P et al (2023) Single-cell RNA-seq reveals a microenvironment and an exhaustion state of T\/NK cells in acute myeloid leukemia. Cancer Sci 114:3873\u20133883","journal-title":"Cancer Sci"},{"key":"4024_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ (2011) T cell exhaustion. Nat Immunol 12:492\u2013499","journal-title":"Nat Immunol"},{"key":"4024_CR34","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng C, Zheng L, Yoo J-K et al (2017) Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169:1342-1356.e16","journal-title":"Cell"},{"key":"4024_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM et al (2016) Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352:189\u2013196","journal-title":"Science"},{"key":"4024_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","volume":"40","author":"A Crawford","year":"2014","unstructured":"Crawford A, Angelosanto JM, Kao C et al (2014) Molecular and transcriptional basis of CD4+ T cell dysfunction during chronic infection. Immunity 40:289\u2013302","journal-title":"Immunity"},{"key":"4024_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fphar.2019.00609","volume":"10","author":"D Liao","year":"2019","unstructured":"Liao D, Wang M, Liao Y et al (2019) A review of efficacy and safety of checkpoint inhibitor for the treatment of acute myeloid leukemia. Front Pharmacol 10:609","journal-title":"Front Pharmacol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04024-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04024-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04024-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T06:48:52Z","timestamp":1745736532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04024-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["4024"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04024-0","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"170"}}